Company: MBIO
Filing Date: 2025-01-22
Form Type: DEF 14C
Source: 0001104659-25-005251
Chunk: 10

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-22
Form: DEF 14C
Chunk 10
---
     1,994 |     |             |      - |     |              |     1,994 |     |            |    * | % |
| Adam J. Chill                                              |     |        |    19,170 |     |             |      - |     |              |    19,170 |     |            |    * | % |
| Michael J. Zelefsky, M.D                                   |     |        |    18,970 |     |             |      - |     |              |    18,970 |     |            |    * | % |
| All current executive officers and directors as a group (7 
 persons)                                                   |     |        |   246,222 |     |             | 50,204 |     |              |   296,426 |     |            |    * | % |
| 5% or Greater Stockholders:                                |     |        |           |     |             |        |     |              |           |     |            |      |   |
| Fortress Biotech, Inc (4)                                  |     |        | 6,552,781 |     |             |      - |     |              | 6,552,781 |     |            | 10.1 | % |

* Less than 1% of our common stock outstanding

| (1) | The address of each of the directors and executive officers                               
 is c/o Mustang Bio, Inc., 377 Plantation Street, Worcester, Massachusetts                 
 01605, and the address of Fortress Biotech, Inc. is c/o Fortress Biotech, Inc., 1111 Kane 
 Concourse, Suite 301, Bay Harbor Island, FL 33154.                                        |

| (2) | Includes                                                                                  
 only options exercisable within 60 days of January 14, 2025 and unvested restricted stock 
 units.                                                                                    |

| (3) | Includes                                                                                    
 33,334 warrants issued by Fortress to each of Mr. Weiss and Dr. Rosenwald that cover shares 
 of our common stock that are owned by Fortress. These do not represent equity compensation  
 by us to either Mr. Weiss or Dr. Rosenwald.                                                 |

| (4) | Includes                                                                                      
 shares underlying 33,334 warrants issued to each of Mr. Weiss and Dr. Rosenwald, and excludes 
 250,000 of Class A Preferred Stock, which are convertible into 16,666 shares of common stock. |